Crescent Biopharma received FDA clearance for CR-002, an antibody-drug conjugate, and plans a Phase 1/2 APOLLO trial starting ...

Apple's new CEO is putting his own stamp on the company and making design a much bigger priority. Bloomberg's Mark Gurman ...

Tom Kloza, chief energy advisor for Gulf Oil, said that it is unlikely President Trump's proposed easing of limits on ...

Summit Therapeutics completed a $2B strategic equity investment from AstraZeneca to accelerate the clinical development of ...

ECARX completed its acquisition of the Flyme software business portfolio for RMB 1.8 billion to bring its operating systems ...

Brian Hartigan, global head of ETFs and index Strategies at Invesco, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ ...

GE HealthCare agreed to acquire SOFIE Biosciences for $945 million in cash to expand its U.S. radiopharmaceutical ...

Clime Capital (ASX:CAM) reported a $13.4 million pre-tax profit for FY26 while receiving a qualified audit opinion regarding ...

Maritana Minerals (ASX:MRT) has secured its final regulatory permits and extended its early works agreement for the Black ...

Etherstack (ASX:ESK) announced plans to reorganise its share premium account via a capital reduction to establish ...

Austral Resources Australia (ASX:AR1) has progressed its proposed $80.7 million acquisition of Hammer Metals (ASX:HMX).

HealthCo Healthcare & Wellness REIT (ASX:HCW) has secured binding lease agreements for its 10 Healthscope hospitals.